-
Blood Cancer Awareness Month: Exploring innovative treatments
23 Sep 2021 19:21 GMT
…
But new and innovative treatments are being explored, according … Society of Hematology and Transfusion Medicine.
cnxps.cmd.push(function … of cancer therapy.”
Doctors are already using the … most successful drugs used to treat multiple myeloma, Bortezomib, is …
-
Global Breast Cancer Drugs Market Trends, Strategies, And Opportunities In The Breast Cancer Drugs Market 2021-2030
20 Sep 2021 11:29 GMT
… Drugs (Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib … (Carfilzomib), Adcetris (Brentuximab Vedotin)), By Treatment Approaches (Key Findings, Chemotherapeutic, MAbs …
-
Global Skin Cancer Drugs Market Trends, Strategies, And Opportunities In The Skin Cancer Drugs Market 2021-2030
13 Sep 2021 10:59 GMT
… Lilly, Meda, Sun Pharmaceutical Industries Ltd.
Regions: … Drugs (Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib … (Brentuximab Vedotin)), By Treatment Approaches (Key Findings, …
-
With November PDUFA Date, FDA Could Approve Biotech's Lead Cell Therapy Soon
27 Aug 2021 08:21 GMT
… 39;s new drug application.
Legend presented longer … be compared to Bortezomib, Lenalidomide, and Dexamethasone … Pharmaceuticals and Medical Devices Agency.
Meanwhile, Zelin noted, the biotech continues … trial is LB1901, an anti-CD4 auto-CAR-T for the treatment …
-
Legend Biotech Reports Second Quarter 2021 Financial Results and Recent Highlights
23 Aug 2021 12:00 GMT
… the treatment of adults with RRMM.
Legend Biotech’s … New Drug Application (NDA) to the Japan Pharmaceuticals and Medical … evaluate the efficacy of bortezomib, lenalidomide and dexamethasone ( … trials, including the initiation of the phase 1 clinical trial …
-
Global Blood Cancer Drugs Market Trends, Strategies, And Opportunities In The Blood Cancer Drugs Market 2021-2030
19 Aug 2021 11:54 GMT
… trials, thus lowering clinical trial costs. Major blood cancer drug … on blood cancer type, drugs, treatment approaches and geography.
… Drugs: MabThera / Rituxan (rituximab), Gleevec/Glivec (Imatinib), REVLIMID® (lenalidomide), VELCADE® (bortezomib …
-
Cancer Therapeutics Market to play a significant role in bringing a $180.19 billion boost to the global economy
12 Oct 2021 14:23 GMT
… demand for personalized medicine along with high potential … of therapeutic targets for treatment of cancer with … Furthermore, pharmaceutical companies are developing new and improved drugs to … both subsidiaries of Genscript Biotech Corporation, to develop, …
-
Antengene submits NDA to Taiwan FDA for selinexor for three indications in hematologic malignancies
15 Jul 2021 08:28 GMT
… indications: in combination with bortezomib and dexamethasone (XVd), or … chief medical officer of Antengene. "Selinexor treatment in … FDA and is the first drug approved for the treatment … and later-phase clinical trials across multiple solid tumor …
-
Janssen Announces U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
12 Jul 2021 12:36 GMT
… S. Food and Drug Administration (FDA) approval of DARZALEX … bortezomib, cyclophosphamide, and dexamethasone is indicated for the treatment … corticosteroids and other medications after the administration of … Biotech, Inc. are part of the Janssen Pharmaceutical …
-
Pharma Stock Roundup: EU Nod to AZN, SNY, JNJ Drugs, Glaxo's New COVID
24 Jun 2021 13:09 GMT
… with cyclophosphamide, bortezomib and dexamethasone for the treatment of newly … submitted a new drug application to the FDA, seeking approval … Glaxo and partner Vir Biotech announced final day 29 … mCSPC.
The NYSE ARCA Pharmaceutical Index rose 0.2% in …
About
© 1995-2021